HRP20100097T1 - Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline - Google Patents
Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline Download PDFInfo
- Publication number
- HRP20100097T1 HRP20100097T1 HR20100097T HRP20100097T HRP20100097T1 HR P20100097 T1 HRP20100097 T1 HR P20100097T1 HR 20100097 T HR20100097 T HR 20100097T HR P20100097 T HRP20100097 T HR P20100097T HR P20100097 T1 HRP20100097 T1 HR P20100097T1
- Authority
- HR
- Croatia
- Prior art keywords
- nonan
- cyclopropyl
- dihydro
- oxo
- fluoro
- Prior art date
Links
- 229960001248 pradofloxacin Drugs 0.000 claims abstract 4
- -1 pradofloxacin trihydrate Chemical class 0.000 claims abstract 4
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004015981A DE102004015981A1 (de) | 2004-04-01 | 2004-04-01 | Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
PCT/EP2005/002953 WO2005097789A1 (de) | 2004-04-01 | 2005-03-19 | Neue kristalline form von 8-cyan-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20100097T1 true HRP20100097T1 (hr) | 2010-04-30 |
Family
ID=34962324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20100097T HRP20100097T1 (hr) | 2004-04-01 | 2010-02-24 | Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline |
Country Status (32)
Country | Link |
---|---|
US (1) | US7977484B2 (sl) |
EP (1) | EP1737859B1 (sl) |
JP (1) | JP5190259B2 (sl) |
KR (1) | KR101217678B1 (sl) |
CN (1) | CN100591681C (sl) |
AR (2) | AR048099A1 (sl) |
AT (1) | ATE450536T1 (sl) |
AU (1) | AU2005231918B2 (sl) |
BR (1) | BRPI0509529B8 (sl) |
CA (1) | CA2561635C (sl) |
CY (2) | CY1109762T1 (sl) |
DE (3) | DE102004015981A1 (sl) |
DK (1) | DK1737859T3 (sl) |
ES (1) | ES2335899T3 (sl) |
GT (1) | GT200500043A (sl) |
HK (1) | HK1104537A1 (sl) |
HR (1) | HRP20100097T1 (sl) |
IL (1) | IL178353A (sl) |
MY (1) | MY140998A (sl) |
NO (1) | NO337279B1 (sl) |
NZ (1) | NZ550226A (sl) |
PE (1) | PE20060170A1 (sl) |
PL (1) | PL1737859T3 (sl) |
PT (1) | PT1737859E (sl) |
RU (1) | RU2383543C2 (sl) |
SI (1) | SI1737859T1 (sl) |
SV (1) | SV2006002070A (sl) |
TW (1) | TWI350755B (sl) |
UA (1) | UA84329C2 (sl) |
UY (1) | UY28828A1 (sl) |
WO (1) | WO2005097789A1 (sl) |
ZA (1) | ZA200608072B (sl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
DE102006010643A1 (de) | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
DE102007026550A1 (de) * | 2007-06-08 | 2008-12-11 | Bayer Healthcare Ag | Extrudate mit verbesserter Geschmacksmaskierung |
EP3579820B1 (en) | 2017-02-13 | 2021-04-28 | Bayer Animal Health GmbH | Liquid composition containing pradofloxacin |
CN115710267A (zh) * | 2022-11-30 | 2023-02-24 | 天津大学 | 一种普拉沙星水合物晶体及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0882049B1 (de) | 1996-02-23 | 2002-11-20 | Bayer Ag | Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate |
DE19854355A1 (de) | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
DE19854357A1 (de) | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
DE19854356A1 (de) | 1998-11-25 | 2000-05-31 | Bayer Ag | Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
DE19908449A1 (de) | 1999-02-26 | 2000-08-31 | Bayer Ag | Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure |
DE19908448A1 (de) | 1999-02-26 | 2000-08-31 | Bayer Ag | Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure |
US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
-
2004
- 2004-04-01 DE DE102004015981A patent/DE102004015981A1/de not_active Withdrawn
-
2005
- 2005-03-10 GT GT200500043A patent/GT200500043A/es unknown
- 2005-03-15 AR ARP050101004A patent/AR048099A1/es not_active Application Discontinuation
- 2005-03-19 JP JP2007505435A patent/JP5190259B2/ja active Active
- 2005-03-19 PT PT05716236T patent/PT1737859E/pt unknown
- 2005-03-19 CA CA2561635A patent/CA2561635C/en active Active
- 2005-03-19 US US11/547,420 patent/US7977484B2/en active Active
- 2005-03-19 BR BRPI0509529A patent/BRPI0509529B8/pt active IP Right Grant
- 2005-03-19 CN CN200580010668A patent/CN100591681C/zh active Active
- 2005-03-19 RU RU2006138362/04A patent/RU2383543C2/ru active
- 2005-03-19 WO PCT/EP2005/002953 patent/WO2005097789A1/de active Application Filing
- 2005-03-19 AT AT05716236T patent/ATE450536T1/de active
- 2005-03-19 DK DK05716236.4T patent/DK1737859T3/da active
- 2005-03-19 PL PL05716236T patent/PL1737859T3/pl unknown
- 2005-03-19 NZ NZ550226A patent/NZ550226A/en unknown
- 2005-03-19 DE DE502005008620T patent/DE502005008620D1/de active Active
- 2005-03-19 AU AU2005231918A patent/AU2005231918B2/en active Active
- 2005-03-19 ES ES05716236T patent/ES2335899T3/es active Active
- 2005-03-19 EP EP05716236A patent/EP1737859B1/de active Active
- 2005-03-19 SI SI200530913T patent/SI1737859T1/sl unknown
- 2005-03-19 UA UAA200611491A patent/UA84329C2/ru unknown
- 2005-03-30 UY UY28828A patent/UY28828A1/es not_active Application Discontinuation
- 2005-03-30 MY MYPI20051428A patent/MY140998A/en unknown
- 2005-03-31 PE PE2005000369A patent/PE20060170A1/es not_active Application Discontinuation
- 2005-03-31 TW TW094110161A patent/TWI350755B/zh active
- 2005-04-01 SV SV2005002070A patent/SV2006002070A/es unknown
-
2006
- 2006-09-28 IL IL178353A patent/IL178353A/en active IP Right Grant
- 2006-09-28 ZA ZA2006/08072A patent/ZA200608072B/en unknown
- 2006-10-26 KR KR1020067022260A patent/KR101217678B1/ko active IP Right Grant
- 2006-10-31 NO NO20064988A patent/NO337279B1/no unknown
-
2007
- 2007-09-05 HK HK07109664.9A patent/HK1104537A1/xx unknown
-
2010
- 2010-01-29 CY CY20101100090T patent/CY1109762T1/el unknown
- 2010-02-24 HR HR20100097T patent/HRP20100097T1/hr unknown
-
2011
- 2011-10-11 CY CY2011018C patent/CY2011018I1/el unknown
- 2011-10-11 DE DE201112100055 patent/DE122011100055I1/de active Pending
-
2016
- 2016-06-28 AR ARP160101954A patent/AR105177A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011093826A3 (en) | Effervescent formulations comprising cefaclor and clavulanic acid as active agents | |
GEP20105082B (en) | (biphenyl) carboxylic acids and derivatives thereof | |
AU2018236805B2 (en) | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives | |
NO20085068L (no) | Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
HRP20100097T1 (hr) | Novi kristalinični oblici 8-cijano-1-ciklopropil-7-(1s,6s-2,8-diazabiciklo[4.3.0]nonan-8-il)-6-fluor-1,4-dihidro-4-okso-3-kinolin-ugljične kiseline | |
MY176873A (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use | |
EA201300669A1 (ru) | Замещенные 1-бензилциклоалкилкарбоновые кислоты и их применение | |
MY163791A (en) | SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS cFMS INHIBITORS | |
MY149731A (en) | Compounds | |
HK1136827A1 (en) | Spirocyclic cyclohexane derivatives | |
NO20076695L (no) | Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser | |
CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
UA88481C2 (ru) | Донепезила фумарат, пригодный для получения фармацевтических композиций | |
TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
AU2010275640A8 (en) | Benzoquinolizinium salt derivatives as anticancer agents | |
JP2008266291A5 (sl) | ||
MY165623A (en) | 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators | |
WO2010135505A3 (en) | Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester | |
TH104388B (th) | รูปผลึกแบบใหม่ของกรด 8-ไซยาโน-1-ไซโคลโพรพิล-7-(1s,6s-2,8-ไดอะซาไบไซโคล[4.3.0] โนแนน-8-อิล)-6-ฟลูออโร-1,4-ไดไฮโดร-4-ไดไฮโดร-4-ออกโซ-3-ควิโนลีนคาร์บอกซิลิก |